Whitebox Advisors’s Trinity Biotech TRIB Stock Holding History

Whitebox Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,695	Closed	-$9.71M	–	437
2014 Q4	$9.71M	Sell	3,695 -1,018	-22%	-$2.63M	0.39%	57
2014 Q3	$12.9M	Buy	4,713 +277	+6%	+$900K	0.5%	47
2014 Q2	$15.3M	Buy	4,436 +1,408	+46%	+$5.01M	0.6%	44
2014 Q1	$11M	Buy	3,028 +979	+48%	+$3.85M	0.47%	46
2013 Q4	$7.73M	Buy	2,049 +121	+6%	+$436K	0.34%	48
2013 Q3	$6.29M	Buy	1,928 +667	+53%	+$1.95M	0.33%	51
2013 Q2	$3.19M	Buy	+1,261	New	+$3.14M	0.17%	68

Other funds holding TRIB

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Whitebox Advisors's TRIB Position: Q1 2015 in Review

Whitebox Advisors sold out of Trinity Biotech (TRIB) in Q1 2015, closing a stake of 3,695 shares — an estimated $9.71M sold.

Whitebox Advisors first reported a position in TRIB in Q2 2013 and held it in 7 quarters. The position peaked at $15.3M in Q2 2014. 88 funds tracked by Wall St. Rank hold TRIB as of Q1 2015.

Whitebox Advisors reported no remaining Trinity Biotech position as of Q1 2015 after selling out during the quarter.
Whitebox Advisors sold 3,695 Trinity Biotech shares in Q1 2015, an estimated $9.71M.
Whitebox Advisors first reported a position in Trinity Biotech in Q2 2013 and held it in 7 quarters.
Whitebox Advisors's Trinity Biotech position peaked at $15.3M in Q2 2014.
88 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2015.

Based on Whitebox Advisors's 13F filing for Q1 2015, filed 12 May 2015.